Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|August 25, 2010
Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitorsShuqun Lin, Stephen T Wrobleski, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinaseJames Kempson, Junqing Guo, Jagabandhu Das, et al.
Science Immunology|April 17, 2021
The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCRJia Jia Lim, Claerwen M Jones, Tiing Jen Loh, et al.
The Journal of Investigative Dermatology|December 26, 2025
A transgenic mouse allows characterisation of the HLA-C*06:02 immunopeptidome in a model of psoriasisAsolina Braun, Jesse I Mobbs, Shanzou Chung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 21, 2022
Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid ArthritisSara Turcinov, Erik Af Klint, Bertrand Van Schoubroeck, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritisAlaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
5-amino-pyrazoles as potent and selective p38α inhibitorsJagabandhu Das, Robert V Moquin, Alaric J Dyckman, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2011
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitorsAlaric J Dyckman, Tianle Li, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2008
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitorsStephen T Wrobleski, Shuqun Lin, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding modeStephen T Wrobleski, Shuqun Lin, T G Murali Dhar, et al.
Pageof 4